[Bendamustine, vincristine, prednisolone (BOP) in therapy of advanced low-grade non-Hodgkin lymphoma]].

R Kath,K Blumenstengel,H J Fricke,H D Peters, K Höffken

Deutsche medizinische Wochenschrift (1946)（2001）

引用 0|浏览0

暂无评分

摘要

Salvage therapy of refractory and relapsed l-NHL with BOP results in a high objective remission rate. Together with a maintenance therapy most patients achieved a long-term disease-free survival. Myelotoxicity and the inversion of the CD4/CD8 ratio were frequently observed side effects.

查看译文

关键词

prednisolon,vincristin,non-hodgkin-lymphomen

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要